Home
CARM
CARM News

Latest Carisma Therapeutics Inc. (CARM) News on June 1, 2025

Carisma Therapeutics Full Year 2024 Earnings: Misses Expectations

Simply Wall St.

2 months ago

Carisma Therapeutics Full Year 2024 Earnings: Misses Expectations

MT Newswires

2 months ago

Carisma Therapeutics Board Approves Revised Operating Plan; Reduces Workforce

Carisma Therapeutics Provides Corporate Updates

PR Newswire

2 months ago

Carisma Therapeutics Provides Corporate Updates

Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

PR Newswire

3 months ago

Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

PR Newswire

4 months ago

Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

MT Newswires

6 months ago

HC Wainwright Downgrades Carisma Therapeutics to Neutral From Buy

MT Newswires

6 months ago

BTIG Downgrades Carisma Therapeutics to Neutral From Buy

Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline

PR Newswire

6 months ago

Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline

Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference

PR Newswire

6 months ago

Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference

MT Newswires

6 months ago

Carisma Therapeutics Says Preclinical Data Support Potential of Engineered Macrophages to Treat Liver Fibrosis

Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024

PR Newswire

6 months ago

Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

PR Newswire

7 months ago

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

PR Newswire

7 months ago

Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024

PR Newswire

7 months ago

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024

Carisma Therapeutics Announces Changes to its Board of Directors

PR Newswire

7 months ago

Carisma Therapeutics Announces Changes to its Board of Directors

Carisma Therapeutics Announces Upcoming Presentations at SITC 2024

PR Newswire

8 months ago

Carisma Therapeutics Announces Upcoming Presentations at SITC 2024

MT Newswires

9 months ago

Carisma Therapeutics, Moderna Expand Collaboration Into Autoimmune Diseases

Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases

PR Newswire

9 months ago

Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases

Carisma Therapeutics to Present at Upcoming Conferences

PR Newswire

9 months ago

Carisma Therapeutics to Present at Upcoming Conferences

CARISMA THERAP (CARM) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

10 months ago

CARISMA THERAP (CARM) Upgraded to Buy: What Does It Mean for the Stock?

MT Newswires

10 months ago

Update: Sesen Bio Completes Li-Metal Cell Production Facility in Korea; Shares Rise Pre-Bell

Carisma Therapeutics Inc. (CARM) Reports Q2 Loss, Tops Revenue Estimates

Zacks

10 months ago

Carisma Therapeutics Inc. (CARM) Reports Q2 Loss, Tops Revenue Estimates

Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

PR Newswire

10 months ago

Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Carisma Therapeutics Announces Expansion of Its Scientific Advisory Board

PR Newswire

10 months ago

Carisma Therapeutics Announces Expansion of Its Scientific Advisory Board

Carisma Therapeutics Announces Upcoming Presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024

PR Newswire

10 months ago

Carisma Therapeutics Announces Upcoming Presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024

Can Carisma Therapeutics (NASDAQ:CARM) Afford To Invest In Growth?

Simply Wall St.

10 months ago

Can Carisma Therapeutics (NASDAQ:CARM) Afford To Invest In Growth?

Carisma Therapeutics Announces Changes to its Board of Directors

PR Newswire

a year ago

Carisma Therapeutics Announces Changes to its Board of Directors

MT Newswires

a year ago

Sector Update: Health Care Stocks Higher Pre-Bell Friday

MT Newswires

a year ago

Sector Update: Health Care

MT Newswires

a year ago

Carisma Therapeutics Debuts Moderna Collaboration With Solid Tumors Investigative Study; Shares Soar Premarket

Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna

PR Newswire

a year ago

Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna

Carisma Therapeutics’ solid tumour therapy obtains FDA Fast Track status

Pharmaceutical Technology

a year ago

Carisma Therapeutics’ solid tumour therapy obtains FDA Fast Track status

MT Newswires

a year ago

Carisma Therapeutics' Potential Solid Tumor Therapy Gets FDA Fast Track Designation

Carisma Therapeutics Granted FDA Fast Track Designation for CT-0525 for the Treatment of HER2-overexpressing Solid Tumors

PR Newswire

a year ago

Carisma Therapeutics Granted FDA Fast Track Designation for CT-0525 for the Treatment of HER2-overexpressing Solid Tumors

Carisma Therapeutics to Participate in the Stifel 2024 Cell Therapy Forum

PR Newswire

a year ago

Carisma Therapeutics to Participate in the Stifel 2024 Cell Therapy Forum

Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders

PR Newswire

a year ago

Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses

Investor's Business Daily

a year ago

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library

Business Wire

a year ago

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap

Investor's Business Daily

a year ago

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap

EnviroGold Global Closes First Tranche of Private Placement

GlobeNewswire

a year ago

EnviroGold Global Closes First Tranche of Private Placement

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

GuruFocus.com

a year ago

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

How markets digested hot jobs print: Top takeaways

Yahoo Finance Video

a year ago

How markets digested hot jobs print: Top takeaways

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

GlobeNewswire

a year ago

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"

PR Newswire

a year ago

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"

Getting smarter: FIA Launches 3-Day Smart Driving Challenge in Samarkand, Powered by Greater Than

PR Newswire

a year ago

Getting smarter: FIA Launches 3-Day Smart Driving Challenge in Samarkand, Powered by Greater Than

3 Major Product Releases at 3Shape Discover Event

PR Newswire

a year ago

3 Major Product Releases at 3Shape Discover Event

Business Wire

a year ago

Net Asset Value(s)

Irish, Czechs hold EU vote after Dutch far-right gains

AFP

a year ago

Irish, Czechs hold EU vote after Dutch far-right gains

Trade the Nvidia Stock Split? The Tried-and-True Method to Make the Best Profits on the Leading AI Stock

Motley Fool

a year ago

Trade the Nvidia Stock Split? The Tried-and-True Method to Make the Best Profits on the Leading AI Stock

GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials

GlobeNewswire

a year ago

GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials

[Latest] Global Virtual Reality In Gaming Market Size/Share Worth USD 103,244.7 Million by 2033 at a 16.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

GlobeNewswire

a year ago

[Latest] Global Virtual Reality In Gaming Market Size/Share Worth USD 103,244.7 Million by 2033 at a 16.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Bitcoin ReoPro 3.0 Transforms Trading with AI Innovation

PR Newswire

a year ago

Bitcoin ReoPro 3.0 Transforms Trading with AI Innovation

Carisma Therapeutics to Participate in the Jefferies Global Healthcare Conference

PR Newswire

a year ago

Carisma Therapeutics to Participate in the Jefferies Global Healthcare Conference

Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte

PR Newswire

a year ago

Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte

Is There An Opportunity With Carisma Therapeutics, Inc.'s (NASDAQ:CARM) 46% Undervaluation?

Simply Wall St.

a year ago

Is There An Opportunity With Carisma Therapeutics, Inc.'s (NASDAQ:CARM) 46% Undervaluation?

Carisma Therapeutics Inc. (CARM) Reports Q1 Loss, Misses Revenue Estimates

Zacks

a year ago

Carisma Therapeutics Inc. (CARM) Reports Q1 Loss, Misses Revenue Estimates

Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

PR Newswire

a year ago

Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024

PR Newswire

a year ago

Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024

Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference

PR Newswire

a year ago

Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference

Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks

a year ago

Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer

PR Newswire

a year ago

Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer

Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

PR Newswire

a year ago

Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

PR Newswire

a year ago

Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Here's Why CARISMA THERAP (CARM) Is a Great 'Buy the Bottom' Stock Now

Zacks

a year ago

Here's Why CARISMA THERAP (CARM) Is a Great 'Buy the Bottom' Stock Now

Carisma Therapeutics to Present at Upcoming Conferences

PR Newswire

a year ago

Carisma Therapeutics to Present at Upcoming Conferences

Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

PR Newswire

a year ago

Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Carisma Therapeutics Announces Changes to its Board of Directors

PR Newswire

a year ago

Carisma Therapeutics Announces Changes to its Board of Directors

Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting

PR Newswire

a year ago

Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting

Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference

PR Newswire

a year ago

Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference

Individual investors account for 30% of Carisma Therapeutics, Inc.'s (NASDAQ:CARM) ownership, while institutions account for 23%

Simply Wall St.

a year ago

Individual investors account for 30% of Carisma Therapeutics, Inc.'s (NASDAQ:CARM) ownership, while institutions account for 23%

Business Wire

a year ago

AMTD Digital’s Entertainment and Movie Businesses Are Estimated to Contribute Significantly to Net Profit

Associated Press Finance

a year ago

Ohio Valley Banc: Q4 Earnings Snapshot

Business Wire

a year ago

AMTD Digital’s Half Yearly Net Profit is Estimated to Increase over 150% Year over Year

First Mid Bancshares (FMBH) Q4 Earnings and Revenues Surpass Estimates

Zacks

a year ago

First Mid Bancshares (FMBH) Q4 Earnings and Revenues Surpass Estimates

Charles Schwab Boosts Its Online Brokerage With Big TD Ameritrade Deal

Investor's Business Daily

a year ago

Charles Schwab Boosts Its Online Brokerage With Big TD Ameritrade Deal

ISG to Publish Report Assessing eMobility Services and Solutions Providers

Business Wire

a year ago

ISG to Publish Report Assessing eMobility Services and Solutions Providers

Evolution Petroleum (EPM) Stock Dips While Market Gains: Key Facts

Zacks

a year ago

Evolution Petroleum (EPM) Stock Dips While Market Gains: Key Facts

Mirum (MIRM) Banks on Livmarli Sales Despite Recent Setback

Zacks

a year ago

Mirum (MIRM) Banks on Livmarli Sales Despite Recent Setback

Cadiz Insiders Placed Bullish Bets Worth US$547.1k

Simply Wall St.

a year ago

Cadiz Insiders Placed Bullish Bets Worth US$547.1k

PRINCETON BANCORP, INC. AGREES TO ACQUIRE CORNERSTONE FINANCIAL CORPORATION

PR Newswire

a year ago

PRINCETON BANCORP, INC. AGREES TO ACQUIRE CORNERSTONE FINANCIAL CORPORATION

3 Undiscovered Small-Cap Stocks to Snap Up Before They Soar

InvestorPlace

a year ago

3 Undiscovered Small-Cap Stocks to Snap Up Before They Soar

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Twin Disc, Incorporated's (NASDAQ:TWIN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Simply Wall St.

a year ago

Twin Disc, Incorporated's (NASDAQ:TWIN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Ceragon Signs an Agreement with a Global Integrator Valued at Approximately $150 Million to Modernize a Tier 1 Operator Network in India

PR Newswire

a year ago

Ceragon Signs an Agreement with a Global Integrator Valued at Approximately $150 Million to Modernize a Tier 1 Operator Network in India

Inventiva draws down the second tranche of €25 million under existing Finance Contract with the European Investment Bank

GlobeNewswire

a year ago

Inventiva draws down the second tranche of €25 million under existing Finance Contract with the European Investment Bank

Cambium (CMBM) Launches Advanced Home Router Solution

Zacks

a year ago

Cambium (CMBM) Launches Advanced Home Router Solution

Jefferies (JEF) Beats Q4 Earnings and Revenue Estimates

Zacks

a year ago

Jefferies (JEF) Beats Q4 Earnings and Revenue Estimates

Spire Global Awarded $9.4 Million Contract by NOAA for Satellite Weather Data

Business Wire

a year ago

Spire Global Awarded $9.4 Million Contract by NOAA for Satellite Weather Data

Catch the Future in Action: LeddarTech Unveils Its Award-Winning LeddarVision ADAS Products and Technology at CES Las Vegas 2024

CNW Group

a year ago

Catch the Future in Action: LeddarTech Unveils Its Award-Winning LeddarVision ADAS Products and Technology at CES Las Vegas 2024

11 Cheap Pot Stocks to Buy

Insider Monkey

a year ago

11 Cheap Pot Stocks to Buy

Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting

Business Wire

a year ago

Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting

Carisma Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire

a year ago

Carisma Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration

PR Newswire

a year ago

First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration

Insider Sell Alert: EVP Scott Schatz Sells 14,138 Shares of Townsquare Media Inc (TSQ)

GuruFocus.com

a year ago

Insider Sell Alert: EVP Scott Schatz Sells 14,138 Shares of Townsquare Media Inc (TSQ)

Here's Why We're A Bit Worried About Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Situation

Simply Wall St.

a year ago

Here's Why We're A Bit Worried About Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Situation

HYZON ANNOUNCES DR. CHRISTIAN MOHRDIECK AS CHIEF TECHNOLOGY OFFICER

PR Newswire

a year ago

HYZON ANNOUNCES DR. CHRISTIAN MOHRDIECK AS CHIEF TECHNOLOGY OFFICER

Hedge funds investors have a lot riding on International Tower Hill Mines Ltd. (TSE:ITH) with 32% ownership

Simply Wall St.

a year ago

Hedge funds investors have a lot riding on International Tower Hill Mines Ltd. (TSE:ITH) with 32% ownership

ADTRAN Holdings (NASDAQ:ADTN) shareholders have endured a 72% loss from investing in the stock a year ago

Simply Wall St.

2 years ago

ADTRAN Holdings (NASDAQ:ADTN) shareholders have endured a 72% loss from investing in the stock a year ago

BlackSky to Participate at Three Upcoming Investor Conferences

Business Wire

2 years ago

BlackSky to Participate at Three Upcoming Investor Conferences

Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte

PR Newswire

2 years ago

Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte

Share on Social Networks: